EPISODE #175: How important are THC:CBD ratios? with Guillermo Moreno-Sanz, PhD, Global Scientific Director of Khiron Life Sciences Corp

The Cannabis Conversation | Medical Cannabis | CBD | Hemp

How important are THC:CBD ratios?

On the latest episode of The Cannabis Conversation, we’re joined by Guillermo Moreno-Sanz, PhD of Khiron Life Sciences Corp - a global provider of cannabis-based medicines and healthcare services.

We explore how THC and CBD work on the body individually, our current understanding on how they interact together, and discuss the recent findings of the King's College study on THC and CBD interaction.

The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.

Get in touch at www.luminorecruit.com/

About Guillermo Moreno-Sanz, PhD

Guillermo Moreno-Sanz, PhD has been dedicated to cannabinoid research for almost 20 years and has authored more than 30 scientific articles and 3 patents describing the role of the endocannabinoid system in pain perception. He received his degree in Biochemistry and Organic Chemistry from the University of Zaragoza, and his PhD in Neurosciences from the Complutense University of Madrid, Spain. He gained extensive international experience with long-term fellowships at the University of Leiden in the Netherlands and at the Department of Drug Discovery and Development at the Italian Institute of Technology in Genoa, Italy. Dr. Moreno-Sanz was awarded a Fulbright Scholarship to complete his Ph.D. in the United States, spending most of his academic career at the University of California, Irvine. There he discovered and characterized a new class of cannabinoid analgesics that are currently in clinical development. In 2017, Dr. Moreno-Sanz served as a consultant to the U.S. National Academies of Sciences in the development of the report "The Health Effects of Cannabis and Cannabinoids" and founded his own consulting firm, Abagune Research, to provide scientific advice and R&D solutions to leading companies in the cannabis industry internationally. In 2020, he joined Khiron Life Sciences Corp as scientific and medical director for Europe and, in 2021 he became the scientific director of the company. Khiron Life Sciences is a global provider of cannabis-based medicines and healthcare services through its network of Zerenia™ clinics, with a presence in Colombia, Peru, Brazil, UK, and Germany.

Resources

Connect with Guillermo Moreno-Sanz, PhD on LinkedIn: https://www.linkedin.com/in/guillermomorenosanz

Khiron Med’s Website: https://khironmed.co.uk/